Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  HIV/AIDS TESTING
A Global Strategic Business Report

This report analyzes the worldwide markets for HIV/AIDS Testing in Millions of US$. The Product segments analyzed include HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 63 companies including many key and niche players worldwide such as Abbott Laboratories Inc., Abbott Molecular Inc., Adaltis Inc., Siemens Healthcare Diagnostics Inc., Biomérieux SA, Bio-Rad Laboratories Inc., Calypte Biomedical Corporation, Celera Group, Gen-Probe, Inc., Innogenetics NV, MedMira Laboratories, Inc., Medical Services International Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics Inc., and Roche Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3401  PAGES:    417
PRICE:    $3950  DATE:       October 2008
COMPANIES:  63  MARKET DATA TABLES:   192
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  HIV/AIDS TESTING (Complete Report) Pages : 417   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3
Definitions.....I-3
HIV/AIDS Screening Tests.....I-3
HIV/AIDS Confirmatory Tests.....I-3
HIV/AIDS Monitoring Tests.....I-3
  
II. EXECUTIVE SUMMARY94$2250
  1. Industry Overview.....II-16 $600  
   Worldwide HIV/AIDS Testing Market – An Analysis.....II-1
Regional Analysis.....II-1
The US.....II-1
Asia Pacific.....II-1
Europe.....II-1
1$100
   Majority of HIV Infections Seen in Developing Countries.....II-2
Segment Analysis.....II-2
HIV/AIDS Screening.....II-2
Confirmatory Test Market.....II-2
1$100
   HIV/AIDS Monitoring Market.....II-3
Growth Drivers.....II-3
Rapid Testing- Displays High Potential.....II-3
1$100
   Molecular Diagnostics Register Strong Growth in Blood Screening Markets.....II-4
Ultra-Rapid HIV-screening Tests- A Strong Fight against HIV-Epidemic.....II-4
Emergency Room Testing to Help HIV Diagnosis.....II-4
OTC HIV Tests to See The Light?.....II-4
1$100
   Leading Players.....II-5
FDA Approved Rapid Test Kits.....II-5
HIV/AIDs Diagnostics Market Participants – Product Matrix.....II-5
2$200
  2. Aids: A Global Epidemic.....II-76 $1200  
   Facts & Figures.....II-7
Table 1: HIV/AIDS Statistics Worldwide: End-2007.....II-7
1$300
   Table 2: Worldwide Living Population Infected with HIV/ AIDS (2007-End) (includes corresponding Graph/Chart).....II-8

Table 3: Worldwide HIV & AIDS Incidences (End-2007): A Regional Breakdown for Living and Newly Infected Cases (includes corresponding Graph/Chart).....II-8
1$300
   Table 4: HIV/AIDS Cases (Living & New Infections) in Adults and Children Worldwide: Breakdown by Region- End 2007 (includes corresponding Graph/Chart).....II-9

Table 5: Worldwide Deaths Due to AIDS (2007-End) (includes corresponding Graph/Chart).....II-9
1$300
   Table 6: HIV/AIDS Cases in Adults and Children Worldwide: Breakdown by Region-End 2007.....II-101$300
   Table 7: Countries With the Highest Number of People Living with HIV: 2003 (includes corresponding Graph/Chart).....II-11
AIDs - A Serious Threat.....II-11
Catching them Young.....II-11
Estimated Number of New HIV Infections in Young People.....II-11
1$300
   Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries.....II-12
1$100
  3. Understanding the Disease.....II-135 $500  
   Mechanism of Action.....II-131$100
   Symptoms.....II-141$100
   Full-Blown AIDS.....II-15
Transmission of HIV.....II-15
1$100
   On the Brighter Side.....II-16
HIV Therapy.....II-16
The Search Continues.....II-16
1$100
   Infection Process - Targets for HIV Therapy.....II-17
1$100
  4. Diagnosis of HIV/Aids.....II-182 $200  
   Testing: The Basis for AIDS Prevention and Treatment.....II-18
Blood Processing.....II-18
The Earliest Time to Detect Infection.....II-18
1$100
   Testing Plagued by Problems Such As.....II-19
Major Drawbacks of Laboratory Diagnosis of HIV Infections.....II-19
Rapid Tests - Suitable for Developing Countries.....II-19
1$100
  5. HIV Tests.....II-2014 $800  
   Testing Subject to Strict Rules.....II-20
Diagnostic Tests.....II-20
I. Antibody Tests.....II-20
A. HIV-1 Screening Tests.....II-20
1$100
   Test Methodology.....II-21
a. Enzyme-linked Immunosorbent Assays/Enzyme Immunoassays (ELISA/EIA).....II-21
1$100
   b. Home AccessHIV-1 test system/Dried Blood Spot.....II-22
c. Rapid Tests.....II-22
1$100
   Generic Assay Formats in Rapid Test.....II-23
The Dot Blot Rapid Test.....II-23
Agglutination Tests.....II-23
1$100
   Solid Phase Test.....II-24
Immunochromatographic strip (ICS) Tests.....II-24
Rapid Serological Tests Vs. ELISA Tests.....II-24
B. HIV-1 Antibody Confirmatory Tests.....II-24
a. The Western Blot Test.....II-24
1$100
   Commonly Used in Developed Countries.....II-25
Interpretation of Results.....II-25
1$100
   Modified Western Blots.....II-26
b. Indirect Immunofluorescent Antibody Assay (IFA).....II-26
c. Line Immunoassay.....II-26
d. Radioimmunoprecipitation Assay (RIPA).....II-26
C. HIV-2 Diagnostic Tests and HIV Group “O.....II-26
1$100
   Testing Protocols.....II-27
Types of Antibody Tests Based on Sample.....II-27
i. Traditional Blood Antibody Tests.....II-27
1$100
   ii. Dried Blood Spot (DBS) Sampling Technique.....II-28
Blood Tests Are Highly Expensive.....II-28
iii. Other Alternatives in Samples.....II-28
Oral Testing for HIV.....II-28
Urine Tests.....II-28
1$100
   II. Viral Identification Assays.....II-29
A. p24 Antigen Test.....II-29
B. Qualitative PCR Tests.....II-29
C. Viral Culture.....II-29
1$100
   Monitoring Tests.....II-30
A. Lymphocyte Analysis.....II-30
1$100
   B. Viral Load Tests.....II-31
Levels of CD4 and Viral Load in AIDS.....II-31
C. Drug Resistance Tests.....II-31
1$100
   Main Types.....II-32
i. Genotyping Tests.....II-32
ii. Phenotyping Tests.....II-32
Molecular Diagnostics and Gene Detection Products.....II-32
DNA Probe-Based Products.....II-32
1$100
   Direct Assays.....II-33
Amplification.....II-33
Amplification Methodologies.....II-33
1$100
  6. Technology Review.....II-342 $200  
   PCR: A Promising Development in HIV/AIDS Monitoring Market.....II-34
DNA Probes are Highly Specific and Sensitive.....II-34
OCA-particles Based Detection System-Offers Increased Accuracy.....II-34
Home HIV Tests: Unfolding a New Era of Testing.....II-34
Yet Nascent.....II-34
1$100
   Not Without Share of Objections.....II-35
Home Access: Monopolizing the Home HIV Test Kit Market.....II-35
Drawbacks of Blood-Based Tests.....II-35
1$100
  7. Regulations.....II-362 $200  
   Overview.....II-36
UN’s Testing Policies in Peacekeeping Force.....II-36
Anonymous Versus Confidential Diagnostic Testing for HIV infection in US.....II-36
Regulatory Approval for Rapid HIV Test Kits in US.....II-36
1$100
   HIV Testing - Mandatory in US Blood Banks.....II-37
1$100
  8. New Product Approvals & Launches.....II-3813 $900  
   Calypte Launches Aware Messenger™.....II-38
Abbott Launches Advanced Viral Load Test.....II-38
MedMira Launches MiraCare™ Rapid Tests with Extended Shelf Life.....II-38
University Researcher Develops Novel HIV/AIDs Antibody Test Kit.....II-38
bioMérieux Introduces VIKIA® HIV 1 / 2 Rapid HIV Test.....II-38
1$100
   Dr Lal Pathlabs Develops Inexpensive HIV Monitoring Test.....II-39
MedMira to Launch Multiplo™ Rapid HIV/HCV Antibody Test.....II-39
Shanghai Kehua Develops New HIV/AIDS Test Kit for Faster Diagnosis.....II-39
INSTI™ HIV Test Kit from bioLytical™ Receives European CE Mark.....II-39
Rockeby Biomed Gains Approval from MOH to Sell OraQuick across Singapore.....II-39
1$100
   FDA Approves Chembio’s Rapid HIV Tests for Sale in the US.....II-40
MiraWell Whole Blood Rapid HIV Test Receives Approval from China SFDA.....II-40
MiraCare Rapid HIV Antibody Test Receives CE Mark.....II-40
Calypte Receives Approval for Marketing Aware Rapid HIV Tests in Kenya.....II-40
1$100
   FDA Approves Bayer’s Automated HIV Antibody Test Product.....II-41
SA Government Approves Marketing of Calypte’s Aware OMT HIV Test Product.....II-41
Calypte Introduces OTC Version of Aware HIV Test in UAE.....II-41
Roche Obtains European Union’s CE Mark for its cobas TaqScreen MPX Test.....II-41
1$100
   MedMira Registers Rapid HIV/ADIS Test Products for Latin American Market.....II-42
bioLytical Gains Health Canada’s Approval for Marketing INSTI HIV Test Kit.....II-42
Calypte’s Aware BSP HIV 1/2 Test Product Receives Malaysian Government’s
  Clearance.....II-42
FDA Approves Upgrades to Reveal G2 Rapid HIV Test.....II-42
MedMira Introduces OTC Version of MiraCare in Select Asian Markets.....II-42
1$100
   Calypte Includes Dried Blood Specimen-Based Testing Capability into HIV-1 BED Incidence
  EIA Test.....II-43
Calypte’s Aware™ HIV-1/2 BSP Approved for Marketing in Zimbabwe.....II-43
FDA Approves Rockville Facility for Manufacturing HIV-1 Urine EIA Screening
  Test.....II-43
OraSure Introduces OraQuick ADVANCE Rapid HIV Test in Mexico.....II-43
1$100
   Adaltis Develops Advanced Detect-HIV™ Test for Early Detection of HIV
  Infection.....II-44
Xenomics Develops HIV DNA Detection Technology.....II-44
Abbott and Celera Diagnostics Receive CE Certification.....II-44
Bio-Rad Receives FDA Approval for HIV-1& HIV 2 Rapid Test.....II-44
1$100
   FDA Approval for MedMira’s Enhanced Rapid HIV Test.....II-45
Roche Receives CE Mark Certification for Virology Tests.....II-45
Roche Receives FDA Approval for COBAS AmpliScreen Test.....II-45
Chembio Diagnostics Launches HIV Stat-Pak Dipstick.....II-45
Medical Services Develops Next Generation HIV Test Kits.....II-45
1$100
   Bio-Rad’s Multispot HIV-1/HIV-2 rapid test Approved by FDA.....II-46
Abbott Receives CE Mark Certification for PCR Test.....II-46
1$100
   Bayer Receives CE Mark Certification for TRUGENE® HIV-1.....II-47
MedMira Receives Health Canada Approval for Rapid HIV Test.....II-47
OraSure Receives FDA Approval for Oral Fluids and Plasma.....II-47
Roche Receives FDA Approval for Diagnostic Test.....II-47
Trinity Receives FDA Waiver for Uni-Gold.....II-47
bioMérieux Unveils VIDAS® HIV Duo Ultra and Duo Quick HIV Tests.....II-47
1$100
   OraQuick® Rapid HIV-1/2 Antibody Assay Approved by the FDA.....II-48
MedMira Launches Reveal™ G2.....II-48
OraSure Launches OraQuick® ADVANCE Rapid HIV Test.....II-48
Celera Diagnostics Obtains FDA Clearance for Enhanced ViroSeq™.....II-48
1$100
   Calypte Unveils HIV-1/2 Oral Fluid Rapid Tests.....II-49
Bio-Rad’s HIV-1/HIV-2 PLUS O EIA Assay Approved by the FDA.....II-49
OraQuick HIV-1 Test Approved by FDA for Use with Venuous Whole Blood.....II-49
Bio-Rad Receives FDA Approval for HIV-1/HIV- 2 PLUS O Test.....II-49
Calypte Introduces Urine Based HIV-1 Assay in Africa.....II-49
1$100
   China Develops Novel HIV Testing Reagent.....II-50
Calypte Receives FDA Approval for Western Blot Supplemetary Test.....II-50
1$100
  9. Recent Industry Activity.....II-5118 $1100  
   MedMira Bags Supply Contract from PAHO.....II-51
MedMira Seeks Patent for Latest Rapid Test Platform.....II-51
Abbott Attains Supplemental FDA Approval for RealTime HIV- 1 Viral Load Test.....II-51
USCDC Awards Federal Grant to District of Columbia for HIV Testing.....II-51
1$100
   Premier Includes Roche COBAS HIV-1 Monitoring Test in Contract.....II-52
MedMira Receives USAID Approval for Reveal G3 Rapid HIV Test.....II-52
Calypte Biomedical Inks Agreement with Fusion Capital.....II-52
Roche Inks Agreement with Clinton Foundation.....II-52
1$100
   Ortho-Clinical Attains FDA Approval for HIV Test.....II-53
Geneart Awarded Patent for HIV Vaccine.....II-53
Crucell’s Adenovirus Vector Enters Phase I Clinical Studies.....II-53
MedMira to Expand Operations in Eastern Europe.....II-53
1$100
   Calypte Initiates Sale of Aware™ HIV-1/2 OMT Oral Fluid Test in India.....II-54
Calypte Receives Approval for Aware HIV-1/2 OMT Test.....II-54
Bundi Opts for SurgiLance Safety Lancet.....II-54
Chembio Diagnostics Receives Sublicense for HIV-2 Patent.....II-54
1$100
   Calypte Receives USAID Approval.....II-55
Roche’s Latest HIV-1 Test Receives FDA Approval.....II-55
Beckman Coulter Receives Grant.....II-55
Oregon Medical Adopts Roche Diagnostics' HIV Test.....II-55
1$100
   OraSure Inks Agreement with Supply Chain Management System.....II-56
Bio-Rad Enters into Multi-Year Agreements with Quest Diagnostics.....II-56
CytoDyn Pockets Advanced Genetic Technologies.....II-56
Aethlon Partners with ImQuest.....II-56
1$100
   Quest Diagnostics Receives License from Pathway.....II-57
OraSure Inks Agreement with Constella Group.....II-57
LabCorp to Offer Fully Automated Real-Time HIV Test of Roche Diagnostics.....II-57
Abbott Receives FDA Approval for RealTime HIV-1 Test.....II-57
1$100
   Abbott Receives Health Canada Approval.....II-58
Novartis Receives Health Canada Approval.....II-58
Medical Services Completes Trials of VScan Hepatitis C and HIV Test Kit.....II-58
Health Canada Approves Versant 440 Molecular Systems.....II-58
OraSure Receives CE Mark for OraQuick ADVANCE HIV Test.....II-58
1$100
   MedMira Receives Approval for Multiplo HBV/HIV/HCV.....II-59
Roche Diagnostics Partners with ARK Diagnostics.....II-59
Roche’ HIV Viral Load Test Used In Clinical Trials.....II-59
Innogenetics and Bio-Rad Ink Licensing Agreement.....II-59
OraSure Bags Contract From Madagascar Government.....II-59
Calypte Receives Approval for Aware(TM) HIV-1/2 OMT Rapid Test.....II-59
Siemens Acquires Bayer Diagnostics.....II-59
1$100
   Gen-Probe’s HIV Test Receives FDA Approval.....II-60
Bayer Receives FDA Approval for Automated HIV Test.....II-60
Inverness Receives Marketing Rights for Rapid HIV Test.....II-60
Clinton Foundation Inks Agreement with Guava Technologies.....II-60
MedMira Inks Distribution Agreement with Voden.....II-60
Roche Bags CE Mark certification.....II-60
1$100
   Chembio Diagnostics Bags Major Contract.....II-61
Calypte Receives Approval for HIV Test.....II-61
Medical Services Expands Distribution Channel in South Africa.....II-61
Rockeby Receives Approval from Singaporean Ministry of Health.....II-61
MedMira Receives SFDA Approval.....II-61
Roche Adopts Primagen’s DFS Technology.....II-61
Calypte and Mineseeker to Supply Aware™ AIDS Test Kit Across Africa.....II-61
1$100
   OraSure Bags US$6 Million Order to Deliver HIV Test Kits.....II-62
Trinity Biotech Enters into Agreement to Deliver Uni- Gold HIV Test Kits to
  PPFA.....II-62
Trinity Biotech Delivers Uni-Gold™ Rapid HIV Test to 340B Prime Vendor Program.....II-62
1$100
   MedMira Bags Order from Exportrade for MiraWell Rapid HIV Tests.....II-63
OraSure Receives Bulk Order for Rapid HIV Tests from CDC.....II-63
MedMira Bags Order from Spree Trading for MiraWell Rapid HIV Tests.....II-63
IRIS Acquires Leucadia with Plans to Introduce HIV & Cancer Testing Products.....II-63
1$100
   Clindia to Distribute MiraCare Rapid HIV Test in the Netherlands.....II-64
MedMira Bags Order from Goodman Medical.....II-64
bioMérieux Bags Contract to Provide Equipment for HIV Viral Load Measurement.....II-64
Novartis Acquires Chiron to Create a New Diagnostics & Vaccines Division.....II-64
Abbott Enters into Agreement with Novation for Supplying OraQuick® ADVANCE™ HIV
  Tests.....II-64
1$100
   Roche Diagnostics Enters into Three-Year Agreement with Premier to Deliver Molecular
  Products.....II-65
MedMira Bags Order to Deliver MiraCare™ HIV Tests Across Europe.....II-65
BD Partners with KEMRI to Provide Modern HIV/AIDS Testing Skills.....II-65
KEMRI Sets Up Facility to Mass Produce AIDS Test Kit for African Market.....II-65
1$100
   MSI Bags Iranian Order for its Rapid VScan HIV/AIDS Test Kits.....II-66
MSI Inks Contract to Deliver VScan HIV Test Kits Across China.....II-66
MSI Inks Deals for Delivery of VScan HIV 1 & 2 Test Kits to Eastern Europe and
  Taiwan.....II-66
Abbott and OraSure Enter into Agreement.....II-66
ViroLogic Offers License to GlaxoSmithKline.....II-66
1$100
   Bio-Rad Sublicenses HIV-2 Rapid Test Patent to OraSure.....II-67
Biotech Cogstate Strikes a Deal with CDC.....II-67
Calypte Receives CDC License for HIV Incidence Test.....II-67
Calypte Biomedical Licences Rapid Test HIV-2 Patent from Bio-Rad.....II-67
OraSure Receives Purchase Order from SAMHSA.....II-67
1$100
   Roche Signs Agreement with Pasteur Institute and Bio-Rad.....II-68
Roche Enters into Agreement with Korean Red Cross.....II-68
Roche, Dade Behring and Chiron Enters into Licensing Agreement.....II-68
Hedley and BioLytical Sign Pact.....II-68
1$100
  10. Focus on Select Global Players.....II-695 $500  
   Abbott Laboratories, Inc. (USA).....II-69
Abbott Molecular, Inc. (USA).....II-69
Adaltis, Inc. (Canada).....II-69
Siemens Healthcare Diagnostics, Inc. (USA).....II-69
1$100
   Biomérieux SA (France).....II-70
Bio-Rad Laboratories, Inc. (USA).....II-70
Calypte Biomedical Corporation (USA).....II-70
1$100
   Celera Group (USA).....II-71
Gen-Probe Inc. (USA).....II-71
Innogenetics NV (Belgium).....II-71
1$100
   MedMira Laboratories, Inc. (Canada).....II-72
Medical Services International Inc. (Canada).....II-72
OraSure Technologies Inc. (USA).....II-72
Ortho-Clinical Diagnostics Inc. (USA).....II-72
1$100
   Roche Diagnostics (Switzerland).....II-73
1$100
  11. Global Market Perspective.....II-74   
   Unit Analytics.....II-74
Table 8: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-74
1$300
   Table 9: World Long-term Projections for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-751$300
   Table 10: World 10-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-761$300
   Table 11: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-771$300
   Table 12: World Long-term Projections for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-781$300
   Table 13: World 10-Year Perspective for HIV/AIDS Screening Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 201 (includes corresponding Graph/Chart).....II-791$300
   Table 14: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-801$300
   Table 15: World Long-term Projections for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-811$300
   Table 16: World 10-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region – Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-821$300
   Dollar Analytics.....II-83
Table 17: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-83
1$300
   Table 18: World Long-term Projections for HIV/AIDS Testing by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-841$300
   Table 19: World 10-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart).....II-851$300
   Table 20: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-861$300
   Table 21: World Long-term Projections for HIV/AIDS Screening Tests by Geographic Region – US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-871$300
   Table 22: World 10-Year Perspective for HIV/AIDS Screening Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-881$300
   Table 23: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-891$300
   Table 24: World Long-term Projections for HIV/AIDS Confirmatory Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-901$300
   Table 25: World 10-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-911$300
   Table 26: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-921$300
   Table 27: World Long-term Projections for HIV/AIDS Monitoring Tests by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-931$300
   Table 28: World 10-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-941$300
III. MARKET134$1950
  1. The United States.....III-132 $1575  
   A. Market Analysis.....III-1
Market Overview.....III-1
Dollar Analysis.....III-1
Unit Analysis.....III-1
Competitive Structure.....III-1
1$75
   Table 29: Leading Players in the HIV Diagnostics Market in the US (2004): Percentage Share Breakdown of Value Sales for Abbott Laboratories, Bio-Rad, BioMerieux, Ortho Clinical Diagnostics and Others (includes corresponding Graph/Chart).....III-2

Table 30: Leading Players in HIV Viral Load Testing Market in the US (2004- 2005E): Percentage Share Breakdown of Value Sales Roche, Bayer, and Others (includes corresponding Graph/Chart).....III-2
1$150
   Rapid HIV Tests Display Rapid Growth.....III-3
Leading Players.....III-3
FDA Approved Rapid Test Kits.....III-3
NAT Tests Score High in Blood Banks.....III-3
1$75
   HIV/AIDS Stats.....III-4
Table 31: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart).....III-4
1$150
   Table 32: AIDS Diagnoses in the US (2005): Breakdown by Ethnic Groups/Race (includes corresponding Graph/Chart).....III-5

Table 33: HIV Infected Persons in US (2002-2005): Percentage Breakup by Ethnic Groups (includes corresponding Graph/Chart).....III-5
1$150
   Table 34: AIDS Cases by Exposure Category in the US: 2005 (includes corresponding Graph/Chart).....III-6
Major End-Users of HIV/AIDS Tests.....III-6
HIV Testing Made Mandatory in Blood Banks.....III-6
1$150
   Physician and Public Health Clinical Market.....III-7
Home HIV Tests.....III-7
Efforts by Organizations.....III-7
1$75
   Vermont Department of Health Suggests HIV Screening for Pregnant Women.....III-8
FDA Approved HIV/AIDS Tests in the US market (1998-2004).....III-8
2$150
   Product Launches.....III-106$325
   Strategic Corporate Developments.....III-169$450
   Key Players.....III-25
Abbott Laboratories, Inc......III-25
1$75
   Abbott Molecular, Inc......III-26
Bio-Rad Laboratories, Inc......III-26
Calypte Biomedical Corporation.....III-26
1$75
   Celera Group.....III-27
Gen-Probe Inc......III-27
OraSure Technologies Inc......III-27
1$75
   Ortho-Clinical Diagnostics Inc......III-28
Siemens Healthcare Diagnostics, Inc......III-28
1$75
   B. Market Analytics.....III-29
Table 35: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-29

Table 36: US Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-29
1$150
   Table 37: US 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-301$150
   Table 38: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-31

Table 39: US Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-31
1$150
   Table 40: US 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-32
1$150
  2. Canada.....III-3311 $925  
   A. Market Analysis.....III-33
Market Overview.....III-33
AIDS/HIV: Some Facts & Figures.....III-33
1$75
   Table 41: AIDS Cases in Canada by Ethnic Status: 2002 – 2006 (includes corresponding Graph/Chart).....III-34

Table 42: AIDS Statistics for Canada by Exposure Category Till June 2007.....III-34
1$150
   HIV Statistics.....III-35
Table 43: AIDS/ HIV Diagnosis Trend in Canada: 1996-2006 (includes corresponding Graph/Chart).....III-35
1$150
   Table 44: AIDS and Positive HIV Cases in Canada by Age Group: 2006-End (includes corresponding Graph/Chart).....III-36
HIV Incidence Among Women.....III-36
1$150
   Historical Stats- Late 1990s.....III-37
Product Launches/Approvals.....III-37
1$75
   Strategic Developments.....III-381$75
   Key Players.....III-39
Adaltis, Inc......III-39
MedMira Laboratories, Inc......III-39
1$75
   Medical Services International, Inc......III-40
B. Market Analytics.....III-40
Table 45: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-40
1$150
   Table 46: Canadian Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-41

Table 47: Canadian 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-41
1$150
   Table 48: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-42

Table 49: Canadian Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-42
1$150
   Table 50: Canadian 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-43
1$150
  3. Japan.....III-444 $475  
   A. Market Analysis.....III-44
Market Overview.....III-44
HIV in Japan.....III-44
B. Market Analytics.....III-44
Table 51: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-44
1$150
   Table 52: Japanese Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-45

Table 53: Japanese 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-45
1$150
   Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-46

Table 55: Japanese Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-46
1$150
   Table 56: Japanese 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-47
1$150
  4. Europe.....III-4816 $1475  
   A. Market Analysis.....III-48
Market Overview.....III-48
Regional Analysis.....III-48
Segment Analysis.....III-48
AIDs/HIV Stats – A Review.....III-48
1$75
   Western Europe.....III-49
Table 57: HIV Diagnosis in Western Europe: Facts and Figures by Country(2006) (includes corresponding Graph/Chart).....III-49
1$150
   Central Europe.....III-50
Table 58: HIV Diagnosis in Central Europe: Facts and Figures by Country(2006) (includes corresponding Graph/Chart).....III-50
1$150
   Eastern Europe.....III-51
Table 59: HIV Diagnosis in Eastern Europe: Facts and Figures by Country (2006) (includes corresponding Graph/Chart).....III-51
1$150
   Regulations.....III-52
Antenatal HIV Testing in Europe.....III-52
Finland.....III-52
Germany.....III-52
Luxembourg.....III-52
Sweden.....III-52
Product Approvals/Launches.....III-52
1$75
   Strategic Developments.....III-532$150
   B. Market Analytics.....III-55
Unit Analytics.....III-55
Table 60: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-55
1$150
   Table 61: European Long-term Projections for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-56

Table 62: European 10-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-56
1$150
   Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-57

Table 64: European Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-57
1$150
   Table 65: European 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-581$150
   Dollar Analytics.....III-59
Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-59
1$150
   Table 67: European Long-term Projections for HIV/AIDS Testing by Geographic Region – France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-601$150
   Table 68: European 10-Year Perspective for HIV/AIDS Testing by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-611$150
   Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-62

Table 70: European Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-62
1$150
   Table 71: European 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-63
1$150
  4a. France.....III-645 $500  
   A. Market Analysis.....III-64
Market Overview.....III-64
Key Player.....III-64
BioMérieux SA.....III-64
Product Launches.....III-64
1$75
   Strategic Developments.....III-65
B. Market Analytics.....III-65
Table 72: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-65
1$150
   Table 73: French Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-66

Table 74: French 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/ AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-66
1$150
   Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-67

Table 76: French Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-67
1$150
   Table 77: French 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-68
1$150
  4b. Germany.....III-695 $500  
   A. Market Analysis.....III-69
Market Overview.....III-69
Few Facts.....III-69
Strategic Corporate Developments.....III-69
1$75
   B. Market Analytics.....III-70
Table 78: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-70
1$150
   Table 79: German Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-71

Table 80: German 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-71
1$150
   Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-72

Table 82: German Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-72
1$150
   Table 83: German 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart).....III-73
1$150
  4c. Italy.....III-745 $575  
   A. Market Analysis.....III-74
Market Overview.....III-74
Few Facts.....III-74
Table 84: HIV/AIDS Prevalence and Mortality Rates by Age Group in Italy: End of 2003.....III-74
1$150
   Strategic Developments.....III-75
B. Market Analytics.....III-75
Table 85: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-75
1$150
   Table 86: Italian Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-76

Table 87: Italian 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-76
1$150
   Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-77

Table 89: Italian Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-77
1$150
   Table 90: Italian 10-Year Perspective for HIV/AIDS esting by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-78
1$150
  4d. The United Kingdom.....III-796 $675  
   A. Market Analysis.....III-79
Market Overview.....III-79
Trends in HIV and AIDS Statistics.....III-79
1$75
   At Risk Groups – A Review.....III-80
Table 91: HIV and AIDS Cases in the UK: Breakdown by Age Group and Gender: Till March 2006 (includes corresponding Graph/Chart).....III-80

Table 92: AIDS Statistics for the UK by Exposure Category: Till June 2007 (includes corresponding Graph/Chart).....III-80
1$150
   B. Market Analytics.....III-81
Table 93: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-81
1$150
   Table 94: UK Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-82

Table 95: UK 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit ales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-82
1$150
   Table 96: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-83

Table 97: UK Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/ AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-83
1$150
   Table 98: UK 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-84
1$150
  4e. Spain.....III-854 $475  
   A. Market Analysis.....III-85
Market Overview.....III-85
B. Market Analytics.....III-85
Table 99: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-85
1$150
   Table 100: Spanish Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-86

Table 101: Spanish 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-86
1$150
   Table 102: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-87

Table 103: Spanish Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-87
1$150
   Table 104: Spanish 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-88
1$150
  4f. Rest of Europe.....III-8910 $775  
   A. Market Analysis.....III-89
Market Overview.....III-89
AIDS Review.....III-89
Austria.....III-89
Russia.....III-89
1$75
   Provision of Antiretroviral Treatment.....III-90
Ukraine.....III-90
Other European Countries.....III-90
1$75
   Key Players.....III-91
Innogenetics NV (Belgium).....III-91
Roche Diagnostics (Switzerland).....III-91
1$75
   Strategic Developments.....III-923$225
   B. Market Analytics.....III-95
Table 105: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-95

Table 106: Rest of Europe Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-95
1$150
   Table 107: Rest of Europe 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-961$150
   Table 108: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-97

Table 109: Rest of Europe Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-97
1$150
   Table 110: Rest of Europe 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-98
1$150
  5. Asia-Pacific.....III-9915 $1175  
   A. Market Analysis.....III-99
Market Overview.....III-99
The Next Epicenter for the AIDS Epidemic.....III-99
China and India: The Worst Affected.....III-99
Review of Select Asian Countries.....III-99
Australia.....III-99
1$75
   Table 111: Number of HIV and AIDs Cases in Australia: Mid1990s to 2006 (includes corresponding Graph/Chart).....III-1001$150
   Table 112: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2006 (includes corresponding Graph/Chart).....III-101
Strategic Development.....III-101
China.....III-101
AIDs/HIV- A Review.....III-101
1$150
   Historical Note.....III-102
Efforts to Combat HIV/AIDs.....III-102
1$75
   Strategic Corporate Developments.....III-1031$75
   India-Rapid Increase in HIV.....III-104 1$75
   Table 113: Estimated Living Population in India with HIV/AIDS Infection (2007): Breakdown by Group (In ‘000).....III-105

Table 114: HIV/AIDS Cases in India in 2005: Percentage Breakup by Mode of Transmission (includes corresponding Graph/Chart).....III-105
Product Launches.....III-105
Strategic Development.....III-105
1$150
   Singapore.....III-106
Strategic Development.....III-106
1$75
   Thailand.....III-107
HIV Cases on Decline.....III-107
Table 115: Number of Live Persons Infection with HIV in Thailand: 2005-End (includes corresponding Graph/Chart).....III-107
Product Launches.....III-107
1$150
   Strategic Developments.....III-108
Philippines.....III-108
2004: Hedley Receives Approval for INSTI(R) HIV-1/HIV-2 Antibody Tests.....III-108
Korea.....III-108
2004: Roche to Supply COBAS AmpliScreen HIV-1 to Korean RedCross.....III-108
Vietnam.....III-108
1$75
   Product Launches/Approval.....III-1091$75
   B. Market Analytics.....III-110
Table 116: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-110
1$150
   Table 117: Asia-Pacific Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-111

Table 118: Asia Pacific 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-111
1$150
   Table 119: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-112

Table 120: Asia-Pacific Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-112
1$150
   Table 121: Asia Pacific 10-Year Perspective for HIV/ AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-113
1$150
  6. Latin America.....III-1148 $875  
   A. Market Analysis.....III-114
Market Overview.....III-114
Epidemics of HIV in Latin America.....III-114
Table 122: People Living with HIV Infection in Latin America by Country:2005 (includes corresponding Graph/Chart).....III-114
1$150
   Trends and Transmission Modes.....III-115
Table 123: HIV/AIDS Prevalence in Latin America: 2002-2004 (in Millions).....III-115
1$150
   Table 124: HIV/ AIDS Prevalence and Mortality Rates by Region till End of 2003.....III-116
Trends in Antiretroviral Treatment.....III-116
1$150
   Product Launches/Approvals.....III-117
Strategic Corporate Developments.....III-117
1$75
   B. Market Analytics.....III-118
Table 125: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-118
1$150
   Table 126: Latin America Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-119

Table 127: Latin America 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-119
1$150
   Table 128: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-120

Table 129: Latin America Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-120
1$150
   Table 130: Latin America 10-Year Perspective for HIV/ AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-121
1$150
  7. Rest of World.....III-12213 $1000  
   A. Market Analysis.....III-122
Market Overview.....III-122
Africa.....III-122
Facing the Brunt of the Disease.....III-122
Mortality Rates on Rise.....III-122
1$75
   Table 131: HIV/AIDS Cases in Africa as of End 2005: Breakdown By Top 20 Countries.....III-1231$150
   Table 132: Adults & Children Deaths Due to AIDS in Africa (2005): Breakdown by Top 10 Countries (includes corresponding Graph/Chart).....III-124

Table 133: Top 20 Countries in Sub-Saharan Africa by HIV/AIDS Prevalence Rate (2005) (includes corresponding Graph/Chart).....III-124
Tanzania to Implement Second Phase of National Program for HIV/AIDS
  Testing.....III-124
1$150
   Uganda – A Review.....III-125
Product Launches/Approvals.....III-125
1$75
   Strategic Developments.....III-1263$225
   Caribbean Nations.....III-129 1$75
   Table 134: HIV/AIDS Prevalence & Mortality Rates in Caribbean Nations Till End of 2005.....III-130
Strategic Developments.....III-130
Iran .....III-130
1$150
   Table 135: HIV infection in Iran: % Breakdown by Exposure Category (includes corresponding Graph/Chart).....III-131
Saudi Arabia: Pre-marriage HIV Test to Become Mandatory.....III-131
B. Market Analytics.....III-131
Table 136: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-131
1$150
   Table 137: Rest of World Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-132

Table 138: Rest of World 10-Year Perspective for HIV/AIDS Testing by Product Segment – Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012.....III-132
1$150
   Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-133

Table 140: Rest of World Long-term Projections for HIV/AIDS Testing by Product Segment –HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-133
1$150
   Table 141: Rest of World 10-Year Perspective for HIV/ AIDS Testing by Product Segment – Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-1341$150
IV. COMPETITIVE LANDSCAPE 171$995
  
Total Companies Profiled: 63 (including Divisions/Subsidiaries - 70 )

Region/Country                 Players


The United States                  47   
Canada                              5
Europe                             10
     France                         1
     Germany                        2
     Italy                          1
     Rest of Europe                 6
Asia-Pacific (Excluding Japan)      6
Middle East                         1
Africa                              1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2009, Global Industry Analysts, Inc., USA.